A detailed history of Summit Financial, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Summit Financial, LLC holds 51,610 shares of DRTS stock, worth $191,473. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,610
Holding current value
$191,473
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$2.9 - $4.51 $149,669 - $232,761
51,610 New
51,610 $232,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $256M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Summit Financial, LLC Portfolio

Follow Summit Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial, LLC with notifications on news.